Stigma Affects Quality of Life in Children With Chronic Skin Conditions
By Lori Solomon HealthDay Reporter
TUESDAY, April 30, 2024 -- Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.
Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the extent of stigma, dependence on disease visibility and severity, and association with mental health and quality of life (QOL) in chronic pediatric skin disease. The analysis included 1,671 children.
The researchers found that stigma scores significantly differed by level of physician-assessed and child/proxy-assessed disease visibility and severity. Only 27.0 percent of children with chronic acne, atopic dermatitis, alopecia areata, and vitiligo had T scores <40 (minimal or no stigma) and 43.8 percent had at least moderate stigma (T score ≥45) versus children with a range of chronic diseases. There was a strong correlation between stigma scores and reduced QOL, depression, anxiety, and poor peer relationships. More than one-fourth of parents (29.4 percent) were aware of bullying of their child, which was strongly associated with stigma. More stigma was reported by girls than boys.
"The findings of this study suggest that physician assessment of disease severity and visibility is insufficient to evaluate the disease impact in the patient/caregiver," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Low Intake of Vitamins, Minerals Tied to Social Isolation in Older Adults
TUESDAY, Oct. 29, 2024 -- A striking considerable number of older adults have lower-than-recommended vitamin and mineral intake, which is associated with social isolation and...
Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
MONDAY, Oct. 28, 2024 -- Children with prenatal cannabis exposure exhibit some differences in aspects of executive function and behavior, according to a study published online...
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
FRIDAY, Oct. 25, 2024 -- Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.